| Name | phenformin |
|---|---|
| Synonyms |
[3H]-Phenformin
Fenformin Normoglucina 1-(diaminomethylidene)-2-(2-phenylethyl)guanidine [14C]-Phenformin 1-phenethylbiguanide MFCD00035039 Imidodicarbonimidic diamide, N-(2-phenylethyl)- Feguanide Phenforminum phenylethyl biguanide phenethylbiguanide Phenformine EINECS 204-057-4 phenformin Cronoformin Fenfoduron Fenformina N-(2-Phenylethyl)imidodicarbonimidic diamide |
| Description | Phenformin (1-phenethylbiguanide) is an orally active antidiabetic and anticancer agent. Phenformin has an incidence of associated lactic acidosis. Phenformin acts through acting AMPK activation and blocking mTOR pathway. Phenformin is also a substrate of P-glycoprotein (P-gp), and an OXPHOS inhibitor. Phenformin induces cancer cell apoptosis[1][2]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 332.2±35.0 °C at 760 mmHg |
| Melting Point | 280-282°C |
| Molecular Formula | C10H15N5 |
| Molecular Weight | 205.260 |
| Flash Point | 154.7±25.9 °C |
| Exact Mass | 205.132751 |
| PSA | 97.78000 |
| LogP | -0.60 |
| Vapour Pressure | 0.0±0.7 mmHg at 25°C |
| Index of Refraction | 1.620 |
| Storage condition | 2-8°C |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Hazard Codes | Xn: Harmful; |
|---|---|
| Risk Phrases | R22 |
| Safety Phrases | S36 |
| WGK Germany | 3 |
| RTECS | DU2200000 |
|
~84%
114-86-3 |
| Literature: Bioorganic and Medicinal Chemistry, , vol. 21, # 8 p. 2305 - 2313 |
|
~%
114-86-3 |
| Literature: Journal of the American Chemical Society, , vol. 81, p. 2220,2223 |
| Precursor 2 | |
|---|---|
| DownStream 1 | |